Semisynthetic human insulin and purified pork insulin do not differ in their biological potency

1984 ◽  
Vol 62 (24) ◽  
pp. 1145-1150 ◽  
Author(s):  
P. Arias ◽  
W. Kerner ◽  
I. Navascués ◽  
G. Schäfauer ◽  
E. F. Pfeiffer
1973 ◽  
Vol 45 (5) ◽  
pp. 633-654 ◽  
Author(s):  
P. H. Sönksen ◽  
Christine V. Tompkins ◽  
M. C. Srivastava ◽  
J. D. N. Nabarro

1. The metabolism of unlabelled monocomponent human insulin and porcine proinsulin was studied in ten normal subjects (five males and five females) by using a priming dose-constant-infusion technique. In each subject, the metabolic clearance rate (MCR) was measured at four separate steady-state hormone concentrations averaging 16–216 μunits/ml (insulin) and 4·2–42·8 ng/ml (proinsulin). 2. For insulin the MCR fell progressively from 34 ml kg−1 min−1 at a mean fasting insulin concentration of 3·8 μunits/ml to 11·4 ml kg−1 min−1 at the highest concentration achieved (280 μunits/ml); for proinsulin MCR averaged 3·7 ml kg−1 min−1 at a mean plasma concentration of 4·2 ng/ml and fell to 2·71 ml kg−1 min−1 at 10·7 ng/ml, remaining constant thereafter at concentrations up to 71 ng/ml. 3. The half-disappearance time (T½) from the plasma, after the end of the infusion, averaged 4·3 min for insulin and 25·6 min for proinsulin. 4. The apparent distribution space (DS) was similar for both hormones (83 ml/kg of insulin and 98·9 ml/kg of proinsulin). 5. There was a direct correlation between T½ and DS for both hormones. 6. Although the higher MCR of insulin was reflected in its shorter T½ there was, for each hormone, no relationship between MCR and T½. 7. The biological potency of porcine proinsulin, as judged by its effect on plasma glucose, was approximately 5% of that of insulin. 8. The responses of serum growth hormone and Cortisol were shown to be directly related to the degree of hypoglycaemia induced.


1983 ◽  
Vol 211 (3) ◽  
pp. 671-676 ◽  
Author(s):  
K Rose ◽  
H De Pury ◽  
R E Offord

Reaction conditions are described that permit the enzyme-assisted semi-synthetic replacement of residue B30 of pig insulin (or of analogue) to proceed in very high yield in 2 h or less. Immobilized trypsin may be used as catalyst, and excess amino acid ester may be recycled after a simple extraction. Alanine-B30 may be replaced by a variety of nucleophiles, including threonine O-t-butyl ether t-butyl ester, in which case the yield of crude product is about 99%. De-protection of the B30 threonyl ester analogue of insulin thus formed then affords human insulin in an overall yield of about 92%, based on pig starting material. The product has full biological potency, as determined by depression of blood glucose concentration in rats, and showed the expected behaviour on radioimmunoassay.


2018 ◽  
Vol 24 ◽  
pp. 77
Author(s):  
Jugal Sharma ◽  
Rajindra Agrawal ◽  
Ritvik Agrawal ◽  
Mohd Rizwan ◽  
Niranjana Ranga ◽  
...  
Keyword(s):  

2018 ◽  
Vol 24 ◽  
pp. 51
Author(s):  
Sanober Parveen ◽  
Hadoun Jabri ◽  
Michael Jakoby

2006 ◽  
Vol 1 (S 1) ◽  
Author(s):  
S Steiner ◽  
M Hompesch ◽  
R Pohl ◽  
P Simms ◽  
A Pfützner ◽  
...  

2008 ◽  
Vol 3 (S 1) ◽  
Author(s):  
Y Ibrahim ◽  
A Schlotterer ◽  
G Kukudov ◽  
P Humpert ◽  
G Rudofsky ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document